This content is in French.
Pembrolizumab and chemoradiotherapy in locally advanced cervical cancer
1 avril 2024
In this randomized, double-blind, placebo-controlled Phase 3 clinical trial, 1,060 adult women with newly diagnosed, high-risk, locally advanced cervical cancer were followed at 176 medical centers in 30 countries…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Domenica Lorusso et al. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical t
View the source
